Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case–control design

Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case–control design

Emerging Microbes & Infections 4,
e64 (October 2015). doi:10.1038/emi.2015.64

Authors: Shan-Shan Zhen, Yue Li, Song-Mei Wang, Xin-Jiang Zhang, Zhi-Yong Hao, Ying Chen, Dan Wang, Yan-Hong Zhang, Zhi-Yong Zhang, Jing-Chen Ma, Peng Zhou, Zhen Zhang, Zhi-Wei Jiang, Yu-Liang Zhao & Xuan-Yi Wang

Source: Emerging Microbes and Infections - October 28, 2015 Category: Infectious Diseases Authors: Shan-Shan ZhenYue LiSong-Mei WangXin-Jiang ZhangZhi-Yong HaoYing ChenDan WangYan-Hong ZhangZhi-Yong ZhangJing-Chen MaPeng ZhouZhen ZhangZhi-Wei JiangYu-Liang ZhaoXuan-Yi Wang Tags: attenuated vaccine case–control study China effectiveness rotavirus Source Type: research